Comprehensive Study Guide to Pharmacokinetics: ADME Processes, ADME, and Metabolic Pathways, and Metabolism

Introduction to Pharmacokinetics

  • Pharmacokinetics is defined as what the body does to a drug once it has been administered.

  • The pharmaceutical journey of a drug involves four primary stages:

    • Absorption

    • Distribution

    • Metabolism

    • Elimination

  • Initially, a drug must be absorbed through the skin or stomach into the bloodstream.

  • Once in the bloodstream, the drug is distributed into fluids both inside and outside of the cells.

  • Following distribution, the body begins metabolizing/biotransforming the drug, primarily in the liver, to facilitate excretion.

  • The final stage is elimination, where the drug and its metabolites are excreted from the body.

Mechanisms of Drug Absorption

  • Absorption is the process by which a drug enters the systemic circulation.

  • Drugs can be administered through various routes, including parenteral, topical, nasal, and rectal.

  • Unless a drug is administered intravenously (IV), it must cross cell membranes to reach systemic circulation.

  • There are four primary mechanisms of drug absorption:

    • Passive Diffusion: Drugs move from an area of higher concentration to an area of lower concentration.

    • Water-soluble molecules move through channels or pores in the membrane.

    • Lipid-soluble molecules pass directly through the cell membrane without assistance.

    • Facilitated Diffusion: Similar to passive diffusion, drugs move from high to low concentration, but they require the assistance of carrier proteins located within the membrane.

    • Active Transport: This is an energy-dependent process where drugs are transported across the membrane against a concentration gradient.

    • The energy for this process is derived from the hydrolysis of Adenosine Triphosphate (ATPATP) into Adenosine Diphosphate (ADPADP).

    • High energy is released from the breaking of the phosphate bond: ATP→ADP+PiATP \rightarrow ADP + P_i.

    • Endocytosis: This process is used for drugs of very large size that cannot fit through channels or carrier protein pockets. The cell membrane engulfs the drug to transport it into the cell.

Bioavailability and Factors Affecting Absorption

  • Absorption is highly variable and depends on factors such as pH, surface area, and blood flow.

  • Bioavailability is the measure of how much of a drug reaches systemic circulation in an unchanged form.

  • When a 100 mg100\,mg oral tablet is taken, less than 100\text{%} actually reaches the systemic circulation due to metabolism in the gut and liver.

  • Intravenous administration bypasses the absorption process entirely, meaning its starting concentration is 100\text{%}.

  • Area Under the Curve (AUC) is used to measure plasma drug concentration over time. It allows for comparison between different formulations and routes of administration.

  • The formula for Bioavailability (FF) is expressed as:

    • F=AUCoralAUCIV×100F = \frac{AUC_{oral}}{AUC_{IV}} \times 100

Drug Distribution and Volume of Distribution (VdV_d)

  • Distribution refers to the movement of a drug from the circulation to the tissues.

  • Several factors influence distribution:

    • Lipophilicity: Highly lipophilic drugs dissolve through cell membranes more easily than hydrophilic drugs.

    • Blood Flow: Organs with higher blood flow, such as the brain, receive drugs faster than areas like the skin. The blood-brain barrier restricts access unless the drug can penetrate it.

    • Capillary Permeability: Liver capillaries have numerous slit junctions allowing large proteins to pass, whereas brain capillaries have no slit junctions.

    • Binding: Drugs may bind to tissue or plasma proteins like albumin. Albumin is a major binding protein that significantly slows down the distribution process.

  • Volume of Distribution (VdV_d) is a theoretical volume required to contain the total amount of administered drug at the same concentration found in the blood plasma.

  • The formula for Volume of Distribution is:

    • Vd=Amount of drug in the bodyConcentration of drug in blood plasmaV_d = \frac{\text{Amount of drug in the body}}{\text{Concentration of drug in blood plasma}}

  • Molecular Weight Correlations:

    • High molecular weight drugs are often protein-bound and do not pass through capillaries easily, leading to high plasma concentrations and lower VdV_d.

    • Low molecular weight/lipophilic drugs distribute extensively into tissues, resulting in a larger VdV_d.

  • VdV_d is essential for estimating drug dosing; drugs with a large VdV_d require a larger dose to achieve the desired plasma concentration.

Drug Elimination and Kinetics

  • Elimination is the removal of a drug from the body, primarily via hepatic, renal, and biliary routes.

  • Total body clearance is the sum of all individual clearance processes.

  • First-Order Kinetics: The amount of drug eliminated over time is directly proportional to the concentration of the drug in the body.

    • A constant fraction of the drug is eliminated per unit of time.

    • For example, if 1000 mg1000\,mg of a drug is present and the elimination rate is 16\text{%}, the specific milligram amount eliminated changes over time, but the percentage remains constant. This produces a curve on a graph.

  • Zero-Order Kinetics: The amount of drug eliminated is independent of the drug concentration; the rate of elimination is constant.

    • For example, if 1000 mg1000\,mg is present and 200 mg200\,mg is eliminated every time period, the fraction changes but the amount stays the same.

    • Aspirin is a notable drug eliminated via zero-order kinetics. This produces a straight line on a graph.

  • Half-Life (t1/2t_{1/2}): The time required to reduce the plasma drug concentration by half. It helps determine the duration of action and predict steady-state levels.

Steady State and Loading Doses

  • Steady State: Achieved when the rate of drug administration equals the rate of drug elimination.

    • At steady state, peak and trough concentrations remain constant after each dose.

    • Steady state is typically attained after approximately 44 to 55 half-lives (t1/2t_{1/2}).

  • The goal is to maintain a steady-state concentration within the therapeutic range (high enough to be effective, low enough to avoid toxicity).

  • Loading Dose: In life-threatening situations (e.g., severe infections), a large initial dose is administered to bypass the time needed to reach steady state and achieve the desired concentration rapidly.

Hepatic Metabolism: Phase I and Phase II Reactions

  • The kidney is the most important organ for elimination, but it cannot efficiently excrete lipid-soluble drugs as they are passively reabsorbed.

  • The liver transforms lipophilic drugs into water-soluble (hydrophilic) substances for kidney excretion via two types of reactions:

    • Phase I Reactions: Aim to make the drug more hydrophilic by introducing or unmasking a polar functional group. These involve:

    • Oxidation

    • Hydrolysis

    • Reduction

    • These are mostly catalyzed by Cytochrome P450 enzymes.

    • Phase II Reactions: If Phase I metabolites are still too lipophilic, they undergo conjugation to add a polar group. These include:

    • Glutathione conjugation

    • Acetylation

    • Sulfation

    • Glucuronidation

    • These produce polar conjugates that cannot cross membranes and are easily eliminated.

Cytochrome P450 Enzymes and Interactions

  • The Cytochrome P450 (CYP) family of enzymes is essential for drug metabolism, specifically Phase I reactions.

  • Key enzymes to remember include:

    • CYP3A4/5CYP3A4/5

    • CYP2D6CYP2D6

    • CYP2C8/9CYP2C8/9

    • CYP1A2CYP1A2

  • Inducers: Drugs that increase the activity of these enzymes, potentially lowering the concentration of other drugs. Mnemonic: B. CRABS.

    • B: Barbiturates

    • C: Carbamazepine

    • R: Rifampin

    • A: Alcohol (chronic use)

    • B: (Included in mnemonic for phonetic structure, often referring to drugs like Phenytoin/Barbiturates list)

    • S: St. John's Wort

    • Phenytoin is also a key inducer.

  • Inhibitors: Substances that decrease enzyme activity, potentially leading to drug toxicity. Mnemonic: G PACMAN.

    • G: Grapefruit

    • P: Protease inhibitors

    • A: Azole antifungals

    • C: Cimetidine

    • M: Macrolides (excluding Azithromycin)

    • A: Amiodarone

    • N: Non-dihydropyridine calcium channel blockers (e.g., Diltiazem and Verapamil)

Questions & Discussion

  • Question: If you take a one hundred mg oral tablet, how much of it gets actually absorbed in unchanged form?

  • Response: It's not a 100\text{%}. Oral medication gets metabolized in the gut and liver, so a good portion is cleared out before reaching systemic circulation.

  • Dialogue: A brief exchange occurred regarding the necessity of preparation, with a confirmation that more preparation was indeed needed.